Total Payments
$41,476
2024 Payments
$463.47
Companies
28
Transactions
244
Medicare Patients
8,078
Medicare Billing
$665,721
Payment Breakdown by Category
Other$32,885 (79.3%)
Food & Beverage$4,047 (9.8%)
Travel$3,344 (8.1%)
Consulting$1,200 (2.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $32,885 | 14 | 79.3% |
| Food and Beverage | $4,047 | 213 | 9.8% |
| Travel and Lodging | $3,344 | 16 | 8.1% |
| Consulting Fee | $1,200 | 1 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $25,079 | 30 | $0 (2023) |
| Amgen Inc. | $14,303 | 58 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $588.22 | 58 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $269.99 | 17 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $188.07 | 14 | $0 (2019) |
| Merck Sharp & Dohme LLC | $164.01 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $156.38 | 11 | $0 (2020) |
| PFIZER INC. | $119.95 | 9 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $69.63 | 5 | $0 (2019) |
| Biosense Webster, Inc. | $65.25 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $463.47 | 24 | Amgen Inc. ($206.95) |
| 2023 | $374.69 | 30 | Novartis Pharmaceuticals Corporation ($129.08) |
| 2022 | $414.89 | 37 | Novartis Pharmaceuticals Corporation ($162.20) |
| 2020 | $8,778 | 12 | Amarin Pharma Inc. ($8,730) |
| 2019 | $16,713 | 51 | Amarin Pharma Inc. ($16,243) |
| 2018 | $3,442 | 31 | Amgen Inc. ($3,162) |
| 2017 | $11,291 | 59 | Amgen Inc. ($10,734) |
All Payment Transactions
244 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 12/02/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/18/2024 | Azurity Pharmaceuticals, Inc. | EDARBYCLOR (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: Cardiology | ||||||
| 10/14/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $14.27 | General |
| 09/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Obesity | ||||||
| 09/16/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/09/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.71 | General |
| Category: Cardiovascular | ||||||
| 08/06/2024 | Azurity Pharmaceuticals, Inc. | EDARBYCLOR (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Cardiology | ||||||
| 06/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $120.29 | General |
| Category: Cardiology | ||||||
| 06/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Cardiology | ||||||
| 05/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/08/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 03/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: Cardiology | ||||||
| 03/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/04/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 02/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: Cardiology | ||||||
| 02/12/2024 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.35 | General |
| Category: Cardiology | ||||||
| 01/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,355 | 2,428 | $534,149 | $137,058 |
| 2022 | 15 | 1,879 | 2,956 | $639,564 | $170,376 |
| 2021 | 17 | 2,303 | 3,615 | $735,548 | $199,111 |
| 2020 | 20 | 2,541 | 3,670 | $649,290 | $159,176 |
Total Patients
8,078
Total Services
12,669
Medicare Billing
$665,721
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 454 | 922 | $334,686 | $90,039 | 26.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 95 | 112 | $54,544 | $15,244 | 27.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 477 | 962 | $56,758 | $11,178 | 19.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 48 | 48 | $33,168 | $8,176 | 24.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 118 | 120 | $29,040 | $6,408 | 22.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 32 | $10,976 | $3,153 | 28.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 14 | 14 | $3,388 | $755.04 | 22.3% |
| 85610 | Blood test, clotting time | Office | 2023 | 35 | 106 | $3,710 | $445.20 | 12.0% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 26 | 27 | $2,403 | $421.74 | 17.6% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 18 | 19 | $1,691 | $412.80 | 24.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 17 | 25 | $1,875 | $400.33 | 21.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 30 | 30 | $1,470 | $354.90 | 24.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 11 | 11 | $440.00 | $69.20 | 15.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 426 | 755 | $274,065 | $79,468 | 29.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 296 | 329 | $160,223 | $44,091 | 27.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 510 | 1,007 | $59,413 | $12,129 | 20.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 29 | 106 | $36,358 | $9,310 | 25.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 38 | 38 | $26,258 | $7,070 | 26.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 121 | 123 | $29,766 | $6,849 | 23.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $9,529 | $2,217 | 23.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2022 | 114 | 114 | $8,729 | $1,986 | 22.7% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2022 | 26 | 26 | $7,159 | $1,749 | 24.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 26 | 27 | $6,534 | $1,466 | 22.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2022 | 120 | 120 | $5,998 | $1,401 | 23.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 34 | 50 | $3,750 | $928.08 | 24.7% |
About Dr. Richard Watson, MD
Dr. Richard Watson, MD is a Cardiovascular Disease healthcare provider based in Morristown, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1003814039.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Watson, MD has received a total of $41,476 in payments from pharmaceutical and medical device companies, with $463.47 received in 2024. These payments were reported across 244 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($32,885).
As a Medicare-enrolled provider, Watson has provided services to 8,078 Medicare beneficiaries, totaling 12,669 services with total Medicare billing of $665,721. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Morristown, NJ
- Active Since 07/13/2005
- Last Updated 02/02/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1003814039
Products in Payments
- Vascepa (Drug) $25,079
- Repatha (Biological) $14,076
- ENTRESTO (Drug) $435.89
- Corlanor (Drug) $211.82
- XARELTO (Drug) $188.07
- VERQUVO (Drug) $164.01
- PRADAXA (Drug) $156.38
- LEQVIO (Drug) $152.33
- MULTAQ (Drug) $147.27
- ELIQUIS (Drug) $142.21
- PRALUENT (Drug) $122.72
- Confidense (Device) $65.25
- PRALUENT ALIROCUMAB INJECTION (Biological) $56.48
- Cardiac Monitoring Suite (Device) $45.08
- WATCHMAN FLX (Device) $39.93
- BRILINTA (Drug) $35.65
- EDARBYCLOR (Drug) $31.96
- Impella (Device) $28.42
- OPTIMIZER (Device) $26.10
- Circulatory Support (Device) $24.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Morristown
Dr. Konstantinos Koulogiannis, M.d, M.D
Cardiovascular Disease — Payments: $140,259
Cardiovascular Disease $140,259
Robert Kipperman, M.d, M.D
Cardiovascular Disease — Payments: $109,121
Cardiovascular Disease $109,121
Dr. Linda Gillam, Md, MD
Cardiovascular Disease — Payments: $71,548
Cardiovascular Disease $71,548
Mark Zucker, Md, MD
Cardiovascular Disease — Payments: $65,768
Cardiovascular Disease $65,768
Leo Marcoff, Md, MD
Cardiovascular Disease — Payments: $31,923
Cardiovascular Disease $31,923
Dr. Timothy Mahoney, M.d, M.D
Cardiovascular Disease — Payments: $19,600
Cardiovascular Disease $19,600